acute myelogenous leukemia
Computerized Detection System for Acute Myelogenous Leukemia in Blood Microscopic Images
7
Original Article Tim-3 as a leukemia stem cell specific marker expressing on bone marrow mononuclear cells is a factor for prognosis evaluation in patients with acute myelogenous leukemia
8
Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope
8
The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients
15
Measurement of the hypercoagulability state in Sudanese patients with acute myelogenous leukemia in Khartoum state
7
Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells
12
Pulmonary Infection Caused by Gymnascella hyalinospora in a Patient with Acute Myelogenous Leukemia
7
Case Report Ovarian granulocytic sarcoma as the primary manifestation of acute myelogenous leukemia
5
Pretreatment of cytokinetics in acute myelogenous leukemia Age related prognostic implications
7
EFFECT OF LONG- AND SHORT-TERM MINICONSOLIDATION ON SURVIVAL OF PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
6
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia
12
On the road: Clinical trials with stem cell extended to non hematologic disease
5
Studies in Steroid Metabolism XXVI Steroid Isolation Studies in Human Leukemia
7
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
8
Clinical significance of high-dose cytarabine added to cyclophosphamide/total-body irradiation in bone marrow or peripheral blood stem cell transplantation for myeloid malignancy
7
High rates of submicroscopic aberrations in karyotypically normal acute lymphoblastic leukemia
12
Supervise Method for Acute Lymphoblastic Leukemia Segmentation and Classification
6
Mutations of c-Cbl in myeloid malignancies
8
Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53 mediated apoptosis
9
Central Nervous System Leukemia and Lymphoma: Computed Tomographic Manifestations
7